INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Elastic N.V. and Certain Officers – ESTC — Neutral
ESTC GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elastic N.V. (“Elastic” or the “Company”) (NYSE: ESTC) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-00785, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Elastic securities between May 31, 2024 and August 29, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Edison International of Class Action Lawsuit and Upcoming Deadlines - EIX — Neutral
EIX GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Edison International (“Edison” or the “Company”) (NYSE: EIX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Venture Global, Inc. of Class Action Lawsuit and Upcoming Deadlines - VG — Neutral
VG GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Venture Global, Inc (“Venture Global” or the “Company”) (NYSE: VG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK — Neutral
GSK GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Northern Technologies International Corporation to Announce Fiscal 2025 Second-Quarter Financial Results and Host Conference Call — Neutral
NTIC GlobeNewsWire — April 03, 2025MINNEAPOLIS, April 03, 2025 (GLOBE NEWSWIRE) -- Northern Technologies International Corporation (NASDAQ: NTIC) today announced that it expects to release its fiscal 2025 second-quarter financial results on Thursday, April 10, 2025, before the market opens. A copy of the news release will be available on the Investor Relations section of NTIC's webpage (www.ntic.com).

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN — Neutral
BHVN GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd (“Biohaven” or the “Company”) (NYSE: BHVN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Constellation Brands, Inc of Class Action Lawsuit and Upcoming Deadlines - STZ — Neutral
STZ GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Constellation Brands, Inc (“Constellation” or the “Company”) (NYSE: STZ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRK — Neutral
MRK GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. (“Merck” or the “Company”) (NYSE: MRK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ready Capital Corporation of Class Action Lawsuit and Upcoming Deadlines - RC — Neutral
RC GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ready Capital Corporation (“Ready” or the “Company”) (NYSE: RC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Atkore Inc of Class Action Lawsuit and Upcoming Deadlines - ATKR — Neutral
ATKR GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Atkore Inc (“Atkore” or the “Company”) (NYSE: ATKR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TFI International Inc. of Class Action Lawsuit and Upcoming Deadlines - TFII — Neutral
TFII GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against TFI International Inc. (“TFI” or the “Company”) (NYSE: TFII). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Civitas Resources, Inc. - CIVI — Neutral
CIVI GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Civitas Resources, Inc (“Civitas” or the “Company”) (NYSE: CIVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NET Power Inc. - NPWR — Neutral
NPWR GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NET Power Inc (“Net Power” or the “Company”) (NYSE: NPWR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

MoneyHero Group to Announce Fourth Quarter and Full Year 2024 Results — Neutral
MNY GlobeNewsWire — April 03, 2025SINGAPORE, April 03, 2025 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY ) (“MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced that it will release its fourth quarter and full year 2024 results on Tuesday, April 29, 2025 before market opens and will hold a related conference call to discuss the results at 8:00 a.m. EDT the same day.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX — Neutral
TFX GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FMC Corporation of Class Action Lawsuit and Upcoming Deadlines - FMC — Neutral
FMC GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis — Neutral
ENLV GlobeNewsWire — April 03, 2025Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globally TMJ causes pain and stiffness in the jaw, making it difficult to chew TMJ osteoarthritis currently has no long-term effective treatments Ness-Ziona, Israel, April 03, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the first patient has been dosed in an investigator-initiated Phase I trial to evaluate the safety, tolerability and initial efficacy of Allocetra™ for injection into the temporomandibular joint …

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting — Neutral
NPCE GlobeNewsWire — April 03, 2025MOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, will be attending and presenting at the upcoming American Academy of Neurology (AAN) 2025 Annual Meeting, which is being held in San Diego from April 5 – 9.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RH – RH — Neutral
RH GlobeNewsWire — April 03, 2025NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Brera Holdings Releases Inspiring Video Presentation Featuring Board Director Chris Gardner and Executive Chairman Daniel McClory, and Juve Stabia President Andrea Langella — Neutral
BREA GlobeNewsWire — April 03, 2025Brera Holdings Executive Chairman Daniel McClory (left) and Juve Stabia President Andrea Langella (right) prior to kick-off at Juve Stabia Dublin, Ireland and Castellammare di Stabia, Italy, April 03, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership (“MCO”) approach, has released a new video presentation highlighting its strategic partnership with Italian football club Juve Stabia srl, “The Second Team of Naples,” and currently 6th in the Italy Serie B table following last weekend's …
